A detailed history of Pinnacle Associates LTD transactions in Johnson & Johnson stock. As of the latest transaction made, Pinnacle Associates LTD holds 1,307,304 shares of JNJ stock, worth $191 Million. This represents 3.36% of its overall portfolio holdings.

Number of Shares
1,307,304
Previous 1,277,707 2.32%
Holding current value
$191 Million
Previous $187 Million 13.45%
% of portfolio
3.36%
Previous 3.01%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$145.48 - $167.38 $4.31 Million - $4.95 Million
29,597 Added 2.32%
1,307,304 $212 Million
Q2 2024

Jul 30, 2024

SELL
$144.38 - $157.78 $3.87 Million - $4.23 Million
-26,821 Reduced 2.06%
1,277,707 $187 Million
Q1 2024

Apr 26, 2024

SELL
$155.22 - $162.74 $430,890 - $451,766
-2,776 Reduced 0.21%
1,304,528 $206 Million
Q4 2023

Jan 19, 2024

BUY
$145.6 - $158.88 $166,129 - $181,282
1,141 Added 0.09%
1,307,304 $205 Million
Q3 2023

Oct 23, 2023

SELL
$155.75 - $174.48 $443,264 - $496,570
-2,846 Reduced 0.22%
1,306,163 $203 Million
Q2 2023

Jul 26, 2023

BUY
$154.35 - $166.11 $3.27 Million - $3.52 Million
21,178 Added 1.64%
1,309,009 $217 Million
Q1 2023

May 04, 2023

SELL
$151.05 - $180.26 $589,397 - $703,374
-3,902 Reduced 0.3%
1,287,831 $200 Million
Q4 2022

Jan 31, 2023

BUY
$160.2 - $179.79 $48,380 - $54,296
302 Added 0.02%
1,291,733 $228 Million
Q4 2022

Jan 25, 2023

SELL
$160.2 - $179.79 $300,855 - $337,645
-1,878 Reduced 0.15%
1,291,431 $0
Q3 2022

Oct 31, 2022

BUY
$161.33 - $179.52 $64.6 Million - $71.9 Million
400,462 Added 44.85%
1,293,309 $211 Million
Q2 2022

Aug 02, 2022

BUY
$168.19 - $186.01 $1.44 Million - $1.59 Million
8,547 Added 0.97%
892,847 $158 Million
Q1 2022

May 05, 2022

SELL
$158.14 - $179.59 $632,243 - $718,000
-3,998 Reduced 0.45%
884,300 $157 Million
Q4 2021

Feb 02, 2022

BUY
$155.93 - $173.01 $6.86 Million - $7.61 Million
44,006 Added 5.21%
888,298 $152 Million
Q3 2021

Oct 19, 2021

SELL
$161.5 - $179.47 $96,254 - $106,964
-596 Reduced 0.07%
844,292 $136 Million
Q2 2021

Aug 02, 2021

BUY
$159.48 - $171.07 $716,543 - $768,617
4,493 Added 0.53%
844,888 $139 Million
Q1 2021

May 12, 2021

SELL
$153.07 - $170.48 $324,661 - $361,588
-2,121 Reduced 0.25%
840,395 $138 Million
Q4 2020

Jan 26, 2021

BUY
$137.11 - $157.38 $12.8 Million - $14.7 Million
93,493 Added 12.48%
842,516 $133 Million
Q3 2020

Oct 23, 2020

BUY
$140.38 - $153.83 $14.1 Million - $15.4 Million
100,199 Added 15.44%
749,023 $112 Million
Q2 2020

Aug 14, 2020

BUY
$128.81 - $155.51 $14 Million - $16.9 Million
108,894 Added 20.17%
648,824 $91.2 Million
Q1 2020

May 13, 2020

BUY
$111.14 - $153.99 $34.8 Million - $48.2 Million
313,283 Added 138.23%
539,930 $70.8 Million
Q4 2019

Feb 03, 2020

BUY
$127.5 - $146.44 $1.39 Million - $1.6 Million
10,902 Added 5.05%
226,647 $33.1 Million
Q3 2019

Nov 08, 2019

BUY
$126.95 - $142.14 $418,300 - $468,351
3,295 Added 1.55%
215,745 $27.9 Million
Q2 2019

Aug 05, 2019

SELL
$131.15 - $144.24 $30,426 - $33,463
-232 Reduced 0.11%
212,450 $29.6 Million
Q1 2019

May 10, 2019

SELL
$125.72 - $139.79 $2.81 Million - $3.13 Million
-22,359 Reduced 9.51%
212,682 $29.7 Million
Q4 2018

Feb 05, 2019

BUY
$122.84 - $147.84 $157,603 - $189,678
1,283 Added 0.55%
235,041 $30.3 Million
Q3 2018

Nov 13, 2018

BUY
$121.58 - $142.88 $219,451 - $257,898
1,805 Added 0.78%
233,758 $32.3 Million
Q2 2018

Aug 08, 2018

BUY
$119.4 - $131.76 $1.67 Million - $1.84 Million
13,956 Added 6.4%
231,953 $28.1 Million
Q1 2018

May 11, 2018

BUY
$125.1 - $148.14 $1.41 Million - $1.67 Million
11,273 Added 5.45%
217,997 $27.9 Million
Q4 2017

Feb 12, 2018

BUY
$131.22 - $143.62 $554,142 - $606,507
4,223 Added 2.09%
206,724 $28.9 Million
Q3 2017

Nov 13, 2017

SELL
$129.47 - $135.38 $482,275 - $504,290
-3,725 Reduced 1.81%
202,501 $26.3 Million
Q2 2017

Aug 09, 2017

BUY
N/A
206,226
206,226 $27.3 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Pinnacle Associates LTD Portfolio

Follow Pinnacle Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Associates LTD with notifications on news.